The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Discover a new treatment approach for Type 2 diabetes that could dramatically reduce, or even eliminate, the need for insulin ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a new medication now available worldwide has the potential to drive that ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.

Nearly 86 per cent of those with type 2 diabetes have been treated with a new procedure that no longer requires insulin, a ...

Investigators added more data to an analysis first published in 2020 and got the same result: ruxolitinib beats other ...

A new breast cancer drug has received quick federal approval after a clinical trial showed it could more than double the time before a common type of breast cancer recurrence worsens.